Edition:
United Kingdom

Seikagaku Corp (4548.T)

4548.T on Tokyo Stock Exchange

1,645JPY
15 Dec 2017
Change (% chg)

¥-51 (-3.01%)
Prev Close
¥1,696
Open
¥1,675
Day's High
¥1,675
Day's Low
¥1,645
Volume
315,200
Avg. Vol
151,803
52-wk High
¥2,109
52-wk Low
¥1,535

Latest Key Developments (Source: Significant Developments)

Ribomic signs collaborative research contract with SEIKAGAKU
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Ribomic Inc <4591.T>:Says it signed collaborative research contract with SEIKAGAKU CORPORATION <<<4548.T>>>.Says two entities mainly cooperate on new technologies development of drug discovery related to Aptamers.  Full Article

Seikagaku signs exclusive worldwide license agreement for treatment for lumbar disc herniation
Monday, 29 Aug 2016 

Seikagaku Corporation <4548.T>: Says the co entered into an exclusive worldwide license agreement(excluding Japan) with Ferring Pharmaceuticals for SI-6603(condoliase), a potential treatment for lumbar disc herniation .Says the co will receive an upfront payment of $5 million and milestone payments up to a maximum total amount of $90 million over multiple years upon future progress in development and commercialization.  Full Article

Seikagaku signs agreement for license of lumbar disc herniation treatment agent with Ferring Pharmaceuticals
Wednesday, 15 Jun 2016 

Seikagaku <4548.T>:Says it signed an agreement for overseas exclusive sale license of lumbar disc herniation treatment agent with Ferring Pharmaceuticals.  Full Article

Seikagaku to retire 1,770,000 treasury shares
Thursday, 12 May 2016 

Seikagaku <4548.T>: Says it to retire 1,770,000 shares (3 pct stake) of its common stock on May 31 .Says the total shares outstanding will be 56,814,093 shares after the retirement.  Full Article

SEIKAGAKU gets manufacturing and marketing approval for ophthalmic surgery adjuvant agent
Monday, 15 Feb 2016 

SEIKAGAKU CORP:Got manufacturing and marketing approval for a ophthalmic surgery adjuvant agent.  Full Article

BRIEF-Ribomic signs collaborative research contract with SEIKAGAKU

* Says it signed collaborative research contract with SEIKAGAKU CORPORATION